T0	Participants 49 89	antihistaminic (H1) effect of bilastine.
T1	Participants 250 284	studies in healthy adult subjects.
T2	Participants 387 471	In the single-dose studies, a total of 183 subjects received oral doses of bilastine
T3	Participants 523 592	In the multiple-dose studies, 127 healthy subjects received bilastine